B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PDPK1

MOLECULAR TARGET

3-phosphoinositide dependent protein kinase 1

NCBI Gene: 517018 compounds

PDPK1 (3-phosphoinositide dependent protein kinase 1) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PDPK1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1midostaurin3.8546
2nintedanib3.6136
3jnj 77066213.0921
4lestaurtinib3.0420
5ruboxistaurin2.9418
6r 4062.8316
7kw 24492.6413
8quinazolinone2.6413
9meridianin c2.5612
10bx 7952.4010
11isoxanthohumol2.309
1226 diaminopurine2.309
13su 0148132.208
14meriolin 11.956
15bdb 5s 6r 7r 9r 16r 16 hydroxy 6 methoxy 5 methyl 7 methylamino 6 7 8 9 15 16 hexahy1.393
16sp6001251.102
17alsterpaullone0.691
18kenpaullone0.691

About PDPK1 as a Drug Target

PDPK1 (3-phosphoinositide dependent protein kinase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented PDPK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PDPK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.